Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Janikova
Prognostic Value of the Interval Between Relapse and Therapy Initiation in Diffuse Large B-Cell Lymphoma Patients. Analysis From the Czech Lymphoma Study Group Database
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
1
2
Related publications
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Molecular Landscape of Relapse/Refractory Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study
Blood Cancer Journal
Oncology
Hematology
Diffuse Large B-Cell Lymphoma
Primary Breast Diffuse Large B-Cell Lymphoma. Clinical Features and Outcome in 55 Patients. Polish Lymphoma Research Group Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
The Graft-Versus-Lymphoma Effect in Diffuse Large B-Cell Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology